Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas
which demonstrates both potential opportunity and possible challenges to therapeutic agonism
also known as PTC124
a feature especially relevant in a compound intended to treat mainly elderly patients
Nitisinone is a remarkable safe drug to use with few side effects reported
Apilimod - CAS# 541550-19-0 ylic acid allowing GLP-1 and GIP toApilimod, also known as STA 5326, is a IL 12 IL 23 inhibitor. Apilimod inhibits IL 12 and IL 23 production cytokines that are involved in autoimmune diseases through the prevention of nuclear translocation of c Rel. Synta Pharmaceuticals Corp is developing apilimod for the potential treatment of Crohn's disease (CD) and other autoimmune diseases. Preclinical studies demonstrated the successful inhibition of IL 12 and IL 23 production by the drug.